Susquehanna International Group
XBIT icon

Susquehanna International Group’s XBiotech XBIT Stock Holding History

Susquehanna International Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,381
Closed -$117K – 14067
2025
Q2 		$117K Buy
39,381
+12,864
+49% +$37.4K ﹤0.01% 11690
2025
Q1 		$85.9K Buy
26,517
+13,749
+108% +$47.4K ﹤0.01% 11629
2024
Q4 		$50.4K Buy
+12,768
New +$87K ﹤0.01% 11674
2024
Q2 		– Sell
-169,812
Closed -$1.38M – 13366
2024
Q1 		$1.38M Buy
169,812
+132,366
+353% +$759K ﹤0.01% 6190
2023
Q4 		$150K Sell
37,446
-3,583
-9% -$14.3K ﹤0.01% 10982
2023
Q3 		$169K Buy
+41,029
New +$205K ﹤0.01% 10428
2023
Q2 		– Sell
-38,163
Closed -$132K – 13283
2023
Q1 		$132K Buy
+38,163
New +$142K ﹤0.01% 11039
2022
Q3 		– Sell
-22,799
Closed -$128K – 14242
2022
Q2 		$128K Buy
+22,799
New +$153K ﹤0.01% 11222
2022
Q1 		– Sell
-13,007
Closed -$145K – 14104
2021
Q4 		$145K Buy
13,007
+2,938
+29% +$38.2K ﹤0.01% 11835
2021
Q3 		$130K Buy
+10,069
New +$160K ﹤0.01% 11894
2021
Q2 		– Sell
-21,664
Closed -$372K – 13357
2021
Q1 		$372K Buy
+21,664
New +$404K ﹤0.01% 10146
2020
Q4 		– Sell
-16,281
Closed -$300K – 11820
2020
Q3 		$311K Sell
16,281
-20,418
-56% -$352K ﹤0.01% 8626
2020
Q2 		$503K Buy
36,699
+12,124
+49% +$170K ﹤0.01% 7346
2020
Q1 		$261K Sell
24,575
-20,014
-45% -$326K ﹤0.01% 8241
2019
Q4 		$832K Buy
44,589
+9,606
+27% +$124K ﹤0.01% 5891
2019
Q3 		$366K Sell
34,983
-30,553
-47% -$249K ﹤0.01% 7898
2019
Q2 		$497K Buy
65,536
+18,849
+40% +$164K ﹤0.01% 7274
2019
Q1 		$514K Buy
46,687
+29,179
+167% +$237K ﹤0.01% 6219
2018
Q4 		$89K Buy
+17,508
New +$71.8K ﹤0.01% 8273
2017
Q2 		– Sell
-30,523
Closed -$292K – 9919
2017
Q1 		$503K Sell
30,523
-37,708
-55% -$494K ﹤0.01% 6478
2016
Q4 		$690K Buy
68,231
+32,363
+90% +$431K ﹤0.01% 6313
2016
Q3 		$483K Buy
+35,868
New +$526K ﹤0.01% 6117

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's XBIT Position: Q3 2025 in Review

Susquehanna International Group sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 39,381 shares — an estimated $117K sold.

Susquehanna International Group first reported a position in XBIT in Q3 2016 and held it in 22 quarters. The position peaked at $1.38M in Q1 2024. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

  • Susquehanna International Group reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 39,381 XBiotech shares in Q3 2025, an estimated $117K.
  • Susquehanna International Group first reported a position in XBiotech in Q3 2016 and held it in 22 quarters.
  • Susquehanna International Group's XBiotech position peaked at $1.38M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.